Literature DB >> 2459957

Selective and persistent deposition and gradual drainage of iodized oil, Lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery.

I Okayasu1, S Hatakeyama, T Yoshida, S Yoshimatsu, K Tsuruta, H Miyamoto, Y Kimula.   

Abstract

The selective and long-term deposition of iodized oil in the hepatocellular carcinoma (HCC) and its gradual drainage were clinicopathologically analyzed in 13 cases. All patients were Japanese and had an intrahepatic arterial injection of Lipiodol (LIP) mixed with Mitomycin C. The comparison among the follow-up computerized tomography (CT) findings, the observation of the soft x-ray radiogram, and histopathologic studies of the surgical or autopsy materials revealed that the selective deposition of LIP in HCC lasted for a long term, particularly in cases treated by LIP combined with transcatheter arterial embolization (TAE). Also revealed was an extremely gradual decrease of LIP from the HCC. It was thus postulated that, mainly, the accumulated macrophages surrounding LIP around the necrotic cancer tissue and, partially, the intrahepatic lymphatic system itself contributed to this drainage. Further, in histologic sections with lipid staining, x-ray microanalysis proved that the lipid droplets in the cancer tissue included highly concentrated iodine, as a deposition of LIP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459957     DOI: 10.1093/ajcp/90.5.536

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Non-surgical treatment of hepatocellular carcinoma.

Authors:  Philip J Johnson
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

2.  Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT).

Authors:  Y Tsushima; Y Unno; J Koizumi; S Kusano
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

Review 3.  Bench-to-clinic development of imageable drug-eluting embolization beads: finding the balance.

Authors:  Andrew L Lewis; Sean L Willis; Matthew R Dreher; Yiqing Tang; Koorosh Ashrafi; Bradford J Wood; Elliot B Levy; Karun V Sharma; Ayele H Negussie; Andrew S Mikhail
Journal:  Future Oncol       Date:  2018-06-26       Impact factor: 3.404

4.  Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin.

Authors:  Mathieu Boulin; Antonin Schmitt; Elisabeth Delhom; Jean-Pierre Cercueil; Maëva Wendremaire; Diane-Charlotte Imbs; Audrey Fohlen; Fabrizio Panaro; Astrid Herrero; Alban Denys; Boris Guiu
Journal:  Eur Radiol       Date:  2015-06-11       Impact factor: 5.315

Review 5.  Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice.

Authors:  Nathan X Chai; Julius Chapiro
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

6.  Tumor uptake of hollow gold nanospheres after intravenous and intra-arterial injection: PET/CT study in a rabbit VX2 liver cancer model.

Authors:  Mei Tian; Wei Lu; Rui Zhang; Chiyi Xiong; Joe Ensor; Javier Nazario; James Jackson; Colette Shaw; Katherine A Dixon; Jennifer Miller; Kenneth Wright; Chun Li; Sanjay Gupta
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

7.  Evaluation of novel formulations for transarterial chemoembolization: combining elements of Lipiodol emulsions with Drug-eluting Beads.

Authors:  Marcus Caine; Ting Chung; Hugh Kilpatrick; Zainab Bascal; Sean Willis; Yiqing Tang; Thierry de Baere; Matthew Dreher; Andrew Lewis
Journal:  Theranostics       Date:  2019-07-28       Impact factor: 11.556

Review 8.  Transarterial Chemoembolization and Unresectable Hepatocellular Carcinoma: A Narrative Review.

Authors:  Nisha Manjunatha; Vinutna Ganduri; Kruthiga Rajasekaran; Shrimahitha Duraiyarasan; Mayowa Adefuye
Journal:  Cureus       Date:  2022-08-26

Review 9.  The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Authors:  Sung Wook Shin
Journal:  Korean J Radiol       Date:  2009-08-25       Impact factor: 3.500

10.  The degree of hepatic arterial blood supply of portal vein tumor thrombus in patients with hepatocellular carcinoma and its impact on overall survival after transarterial chemoembolization.

Authors:  Juxian Sun; Jie Shi; Bin Huang; Fantian Cheng; Weixing Guo; Wan Yee Lau; Shuqun Cheng
Journal:  Oncotarget       Date:  2017-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.